Blue Chip Stocks Bank Stocks Consumer Industrials

ASX Confession Season Is In Full Swing! Which Stocks Could Follow Cochlear In Downgrading Guidance?

ASX Confession Season got into full swing yesterday with Cochlear's guidance downgrade that saw over $4bn in shareholder value wiped out. It is that time that happens every year -…

ByNick Sundich

22

Apr 2026

Blue Chip Stocks Healthcare Stocks

Shares In Cochlear (ASX:COH) Plunge Over 35% As FY26 Guidance Is Slashed By Nearly A Third! Is It A Buy The Dip Opportunity?

If you own shares in Cochlear (ASX:COH), you had a pretty bad morning. The company delivered one of the most significant earnings guidance downgrades in its listed history this morning,…

ByNick Sundich

13

Apr 2026

Blue Chip Stocks Gold Stocks Healthcare Stocks Mining Stocks Small Caps Stocks Tech Stocks Technology Telecommunications Stocks Travel Stocks

Here Are 4 Stock Market Sectors With High Margins, And 4 With Low Margins!

Many investors may prefer stock market sectors with high margins over those with low margins. Profit margins are one of the simplest signals investors reach for when assessing business quality,…

ByNick Sundich

30

Mar 2026

Healthcare Stocks

The 4 Best ASX Healthcare Stocks to Buy as the Sector Trades at Two-Decade Valuation Lows

4 ASX Healthcare Stocks to Buy at Valuation Lows ASX healthcare stocks have had a brutal run. Five years of underperformance, persistent earnings downgrades, and aggressive rate hikes have pushed…

ByUjjwal Maheshwari

14

Feb 2026

Healthcare Stocks

Why ASX Healthcare Stocks Are Crashing- and Which One Looks Like a Buy

ASX healthcare stocks are crashing- which one is worth buying now? Three of Australia's most premium ASX healthcare stocks have been crushed in the same week. CSL (ASX: CSL) has…

ByUjjwal Maheshwari

13

Feb 2026

Blue Chip Stocks Healthcare Stocks

Cochlear (ASX:COH) Down 16% on a Softer Half, What the Market Is Really Pricing

Cochlear had a softer start to its half yearly result, with sales of A$1.1 billion down around 1%. The bigger issue for investors was underlying net profit, which appears to…

ByCharlie Youlden

09

Jan 2026

Blue Chip Stocks Healthcare Stocks Large Caps Uncategorized

Cochlear (ASX:COH) is still a long term growth story you should listen to

Cochlear is one of few stocks that has created immense shareholder value and has also greatly improved the lives of its users. Yes, this can be said with respect to…

ByNick Sundich

01

Oct 2025

Biotech Stocks Healthcare Stocks Mid Cap Stocks

EBR Systems (ASX:EBR): Another heart-focused medtech that has gained FDA approval

Mere days after Artrya (ASX:AYA) obtained FDA approval for its heart-health technology, EBR Systems (ASX:EBR) has achieved that same feat. The company made a surprising 15% plunge on the day of…

ByNick Sundich

02

Sep 2025

Bank Stocks Basic Materials Blue Chip Stocks Consumer Copper Stocks Dividend Stocks Energy Stocks ETF Financials Gold Stocks Healthcare Stocks Industrials Iron Ore Stocks Large Caps Life Sciences Lithium Stocks Mining Stocks Penny Stocks Property Rare Earths Stocks Resources Retail Semiconductor stocks Small Caps Stocks Tech Stocks Technology Uranium Stocks

ASX stocks in America: Here are 4 performing well and 4 performing poorly

You might think ASX stocks in America are doing better than peers which are not there because the USA is a much bigger market. In reality, this is not always…

ByNick Sundich

12

May 2025

Blue Chip Stocks Industrials

How will stocks be impacted by tariffs? Here are 6 victims on the ASX and how they’re responding

How will stocks be impacted by tariffs? Its a long story, but few stocks can say that there'll be no impact. Even companies which could arguably be beneficiaries (like ship…

ByNick Sundich

ASX Confession Season Is In Full Swing! Which Stocks Could Follow Cochlear In Downgrading Guidance?

Shares In Cochlear (ASX:COH) Plunge Over 35% As FY26 Guidance Is Slashed By Nearly A Third! Is It A Buy The Dip Opportunity?

Here Are 4 Stock Market Sectors With High Margins, And 4 With Low Margins!

The 4 Best ASX Healthcare Stocks to Buy as the Sector Trades at Two-Decade Valuation Lows

Why ASX Healthcare Stocks Are Crashing- and Which One Looks Like a Buy

Cochlear (ASX:COH) Down 16% on a Softer Half, What the Market Is Really Pricing

Cochlear (ASX:COH) is still a long term growth story you should listen to

EBR Systems (ASX:EBR): Another heart-focused medtech that has gained FDA approval

ASX stocks in America: Here are 4 performing well and 4 performing poorly

How will stocks be impacted by tariffs? Here are 6 victims on the ASX and how they’re responding

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Stocks in Spotlight

Add Your Heading Text Here